A detailed history of Fox Hill Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Fox Hill Wealth Management holds 30,348 shares of NVO stock, worth $3.19 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
30,348
Previous 28,438 6.72%
Holding current value
$3.19 Million
Previous $4.06 Billion 10.98%
% of portfolio
1.99%
Previous 2.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $227,423 - $277,752
1,910 Added 6.72%
30,348 $3.61 Billion
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $14,479 - $17,335
118 Added 0.42%
28,438 $4.06 Billion
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $1.59 Million - $2.11 Million
15,525 Added 121.34%
28,320 $3.64 Billion
Q4 2023

Apr 17, 2024

BUY
$87.78 - $105.45 $1.12 Million - $1.35 Million
12,795 New
12,795 $1.32 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fox Hill Wealth Management Portfolio

Follow Fox Hill Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Hill Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Fox Hill Wealth Management with notifications on news.